Nova 401(k) Associates
|
Trane Technologies
|
AimPoint Pension Group
|
Defined Contribution Account Manager with a Life! Nova 401(k) Associates
|
DC Plan Consultant/Administrator Dynamic Pension Services, Inc.
|
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
Press Releases by Date | Press Releases by Company Name
Press Release DOL Reaches Agreement to Restore $5.45 Million to Texas-Based Employee Stock Ownership Plan |
Issued by Employee Benefits Security Administration [EBSA], U.S. Department of Labor July 1, 2018 |
LUBBOCK, TX - The U.S. Department of Labor has entered into an agreement with the fiduciaries of Cactus Feeders Inc. Employee Stock Ownership Plan (ESOP) who will repay $5.45 million in plan losses to the ESOP. The agreement resolves a March 10, 2016, civil suit brought by the Department alleging fiduciaries failed to fulfill their obligations under the Employee Retirement Income Security Act (ERISA) of 1974. The allegations stem from a December 2010 stock transaction that resulted in the ESOP overpaying for the outstanding shares of the company. Lubbock National Bank, the ESOP's trustee, has also agreed to take steps that will ensure it fulfills its fiduciary obligations in the future. These include agreeing to an extensive list of actions and conduct that prudent fiduciaries undertake when evaluating whether, for what value, and under what conditions an ESOP should purchase employer stock. The express terms are found in the comprehensive settlement agreement approved by the court on June 15, 2018. "ESOP fiduciaries must only act in the interests of the plan's participants and beneficiaries," said Deborah Perry, Employee Benefits Security Administration Regional Director in Dallas. "The U.S. Department of Labor will take all actions necessary to ensure that fiduciaries live up to their legal obligations." |
Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink. |